Resources Contact Us Home
Recombinant toxin fragments

Image Number 4 for United States Patent #8017134.

A single polypeptide is provided which comprises first and second domains. The first domain enables the polypeptide to cleave one or more vesicle or plasma-membrane associated proteins essential to exocytosis, and the second domain enables the polypeptide to be translocated into a target cell or increases the solubility of the polypeptide, or both. The polypeptide thus combines useful properties of a clostridial toxin, such as a botulinum or tetanus toxin, without the toxicity associated with the natural molecule. The polypeptide can also contain a third domain that targets it to a specific cell, rendering the polypeptide useful in inhibition of exocytosis in target cells. Fusion proteins comprising the polypeptide, nucleic acids encoding the polypeptide and methods of making the polypeptide are also provided. Controlled activation of the polypeptide is possible and the polypeptide can be incorporated into vaccines and toxin assays.

  Recently Added Patents
Tablet computer
Systems and methods for universal enhanced log-in, identity document verification and dedicated survey participation
Acoustic reconfiguration devices and methods
Bezel-less electronic display
Power converter and method including noise suppression by controlling phase shifting of converter cells
Delay lines, amplifier systems, transconductance compensating systems and methods of compensating
Valved, microwell cell-culture device and method
  Randomly Featured Patents
Method of customizing a memory lifespan management policy in an electronic token
Ink transfer medium of the electrically fusible type and method of making same
Perfectioning in reply type radar systems, in particular the SSR type
Fruit peeler
Rubber toughened blends
Lens system and projector using the same
Half-pixel motion compensation controller accepting MPEG2
System and method for managing operating system option values
Sound-producing device